Amgen Inc (AMGN)
264.26
+0.26
(+0.10%)
USD |
NASDAQ |
Dec 24, 13:00
264.60
+0.34
(+0.13%)
After-Hours: 13:44
Amgen Research and Development Expense (Quarterly): 1.45B for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Eli Lilly and Co | 2.734B |
| Merck & Co Inc | 5.862B |
| Pfizer Inc | 2.598B |
| Regeneron Pharmaceuticals Inc | 1.272B |
| Viking Therapeutics Inc | 22.78M |